Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lagasse

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Gastroenterologie Clinique Et Biologique|January 1, 1997
[Acute thrombosis of the portal system. Treatment with alteplase and heparin or with heparin alone in 10 patients]J P Lagasse, M L Bahallah, N Salem, et al.
European Journal of Cancer (Oxford, England : 1990)|October 22, 2018
FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trialJ B Bachet, O Lucidarme, C B Levache, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2025
Effect of 5 years of CT-scan and CEA follow-up on survival endpoints in patients with colorectal cancer: the PRODIGE-13 FFCD phase III trialC Lepage, J-M Phelip, L Cany, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Gastroenterologie Clinique Et Biologique|January 1, 1997
[Acute thrombosis of the portal system. Treatment with alteplase and heparin or with heparin alone in 10 patients]J P Lagasse, M L Bahallah, N Salem, et al.
European Journal of Cancer (Oxford, England : 1990)|October 22, 2018
FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trialJ B Bachet, O Lucidarme, C B Levache, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2025
Effect of 5 years of CT-scan and CEA follow-up on survival endpoints in patients with colorectal cancer: the PRODIGE-13 FFCD phase III trialC Lepage, J-M Phelip, L Cany, et al.
Pageof 4